GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » INIFY Laboratories AB (OSL:INIFY) » Definitions » 3-Year EBITDA Growth Rate

INIFY Laboratories AB (OSL:INIFY) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is INIFY Laboratories AB 3-Year EBITDA Growth Rate?

INIFY Laboratories AB's EBITDA per Share for the three months ended in Dec. 2024 was kr-0.30.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of INIFY Laboratories AB's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, INIFY Laboratories AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


INIFY Laboratories AB's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, INIFY Laboratories AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where INIFY Laboratories AB's 3-Year EBITDA Growth Rate falls into.


;
;

INIFY Laboratories AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


INIFY Laboratories AB  (OSL:INIFY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


INIFY Laboratories AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of INIFY Laboratories AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


INIFY Laboratories AB Business Description

Traded in Other Exchanges
N/A
Address
Scheeles vag 3, Solna, SWE, 171 65
INIFY Laboratories AB provides cancer diagnostics through ultra-modern laboratory services within pathology. It uses a fully digital, standardized, and AI-supported workflow to optimize quality and response times, initially within the prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer's organization.

INIFY Laboratories AB Headlines

No Headlines